Literature DB >> 33502277

Imaging Biomarkers to Assess Response to Immune Checkpoint Inhibitors in Solid Tumors to Tailor Therapy.

Ronald M Summers1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33502277      PMCID: PMC7997611          DOI: 10.1148/radiol.2021204407

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  9 in total

1.  Texture analysis in radiology: Does the emperor have no clothes?

Authors:  Ronald M Summers
Journal:  Abdom Radiol (NY)       Date:  2017-02

2.  A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.

Authors:  Roger Sun; Elaine Johanna Limkin; Maria Vakalopoulou; Laurent Dercle; Stéphane Champiat; Shan Rong Han; Loïc Verlingue; David Brandao; Andrea Lancia; Samy Ammari; Antoine Hollebecque; Jean-Yves Scoazec; Aurélien Marabelle; Christophe Massard; Jean-Charles Soria; Charlotte Robert; Nikos Paragios; Eric Deutsch; Charles Ferté
Journal:  Lancet Oncol       Date:  2018-08-14       Impact factor: 41.316

3.  A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors.

Authors:  Marta Ligero; Alonso Garcia-Ruiz; Cristina Viaplana; Guillermo Villacampa; Maria V Raciti; Jaid Landa; Ignacio Matos; Juan Martin-Liberal; Maria Ochoa-de-Olza; Cinta Hierro; Joaquin Mateo; Macarena Gonzalez; Rafael Morales-Barrera; Cristina Suarez; Jordi Rodon; Elena Elez; Irene Braña; Eva Muñoz-Couselo; Ana Oaknin; Roberta Fasani; Paolo Nuciforo; Debora Gil; Carlota Rubio-Perez; Joan Seoane; Enriqueta Felip; Manuel Escobar; Josep Tabernero; Joan Carles; Rodrigo Dienstmann; Elena Garralda; Raquel Perez-Lopez
Journal:  Radiology       Date:  2021-01-26       Impact factor: 11.105

4.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Authors:  Suzanne L Topalian; F Stephen Hodi; Julie R Brahmer; Scott N Gettinger; David C Smith; David F McDermott; John D Powderly; Richard D Carvajal; Jeffrey A Sosman; Michael B Atkins; Philip D Leming; David R Spigel; Scott J Antonia; Leora Horn; Charles G Drake; Drew M Pardoll; Lieping Chen; William H Sharfman; Robert A Anders; Janis M Taube; Tracee L McMiller; Haiying Xu; Alan J Korman; Maria Jure-Kunkel; Shruti Agrawal; Daniel McDonald; Georgia D Kollia; Ashok Gupta; Jon M Wigginton; Mario Sznol
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

5.  Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis.

Authors:  Steve Lu; Julie E Stein; David L Rimm; Daphne W Wang; J Michael Bell; Douglas B Johnson; Jeffrey A Sosman; Kurt A Schalper; Robert A Anders; Hao Wang; Clifford Hoyt; Drew M Pardoll; Ludmila Danilova; Janis M Taube
Journal:  JAMA Oncol       Date:  2019-08-01       Impact factor: 31.777

Review 6.  Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors.

Authors:  Ming Yi; Dechao Jiao; Hanxiao Xu; Qian Liu; Weiheng Zhao; Xinwei Han; Kongming Wu
Journal:  Mol Cancer       Date:  2018-08-23       Impact factor: 27.401

7.  Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers.

Authors:  S Trebeschi; S G Drago; N J Birkbak; I Kurilova; A M Cǎlin; A Delli Pizzi; F Lalezari; D M J Lambregts; M W Rohaan; C Parmar; E A Rozeman; K J Hartemink; C Swanton; J B A G Haanen; C U Blank; E F Smit; R G H Beets-Tan; H J W L Aerts
Journal:  Ann Oncol       Date:  2019-06-01       Impact factor: 32.976

8.  The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.

Authors:  Alex Zwanenburg; Martin Vallières; Mahmoud A Abdalah; Hugo J W L Aerts; Vincent Andrearczyk; Aditya Apte; Saeed Ashrafinia; Spyridon Bakas; Roelof J Beukinga; Ronald Boellaard; Marta Bogowicz; Luca Boldrini; Irène Buvat; Gary J R Cook; Christos Davatzikos; Adrien Depeursinge; Marie-Charlotte Desseroit; Nicola Dinapoli; Cuong Viet Dinh; Sebastian Echegaray; Issam El Naqa; Andriy Y Fedorov; Roberto Gatta; Robert J Gillies; Vicky Goh; Michael Götz; Matthias Guckenberger; Sung Min Ha; Mathieu Hatt; Fabian Isensee; Philippe Lambin; Stefan Leger; Ralph T H Leijenaar; Jacopo Lenkowicz; Fiona Lippert; Are Losnegård; Klaus H Maier-Hein; Olivier Morin; Henning Müller; Sandy Napel; Christophe Nioche; Fanny Orlhac; Sarthak Pati; Elisabeth A G Pfaehler; Arman Rahmim; Arvind U K Rao; Jonas Scherer; Muhammad Musib Siddique; Nanna M Sijtsema; Jairo Socarras Fernandez; Emiliano Spezi; Roel J H M Steenbakkers; Stephanie Tanadini-Lang; Daniela Thorwarth; Esther G C Troost; Taman Upadhaya; Vincenzo Valentini; Lisanne V van Dijk; Joost van Griethuysen; Floris H P van Velden; Philip Whybra; Christian Richter; Steffen Löck
Journal:  Radiology       Date:  2020-03-10       Impact factor: 29.146

9.  Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer.

Authors:  Chad Tang; Brian Hobbs; Ahmed Amer; Xiao Li; Carmen Behrens; Jaime Rodriguez Canales; Edwin Parra Cuentas; Pamela Villalobos; David Fried; Joe Y Chang; David S Hong; James W Welsh; Boris Sepesi; Laurence Court; Ignacio I Wistuba; Eugene J Koay
Journal:  Sci Rep       Date:  2018-01-31       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.